
To compare the zzso of zzso versus zzso for the treatment of glaucoma and zzso hypertension, a zzso zzso was developed to estimate the annual costs and cost per treatment success zzso for zzso zzso zzso compared with zzso zzso zzso Medication costs for the model were zzso from published zzso Clinical assumptions for the model were based on the treatment success rates from one zzso controlled clinical trial comparing zzso versus zzso zzso zzso and zzso respectively), and another zzso controlled clinical trial comparing zzso versus zzso zzso and zzso zzso Treatment success was defined as the percentage of patients achieving various target zzso zzso A larger percentage of patients achieved low target zzso on zzso than on zzso The cost per treatment success for patients who started treatment on zzso zzso was less than for patients started on zzso despite the fact that the estimated yearly costs were similar for these zzso In this model zzso was found to be more cost-effective than zzso given the average wholesale price of these medications and the assumptions of the zzso zzso about clinical success at the 3- and zzso decision zzso 

